Scientists from around the world are calling for urgent action to protect, restore, and sustainably manage one of the ocean’s least known yet most important ecosystems: the Marine Animal Forests.
Author Archive
Results Announcement V SciencePhoto_IN 2025
From the #SciencePhoto_IN team, we are happy to announce the winners of the 5th IN Science Photo Contest. We would like to thank all the participants for your work, highlighting the high quality of the images and videos that have been sent for this edition. We appreciate your participation in this type of event as it highlights a very important part of your work and also allows us to bring the science generated at the IN closer to the general public. As last year, the IN 2026 Calendar has been prepared with the 12 selected photographs, combining the Jury and Social Networks modalities. A copy will be given to each of the 12 selected authors on December 19th at the end of the Christmas Meeting!
Please find attached a pdf file with the winners of both categories and the 3 prizes as well as the 12 images selected for the IN 2026 Calendar:
- Jury’s Prize: a selection based on the opinion of a committee composed of 10 IN research, management and technical staff.
- Jury’s Honorable Mention: the second best image as voted by the Jury members.
- Social Media’s Prize: a selection based on the public impact of the images disseminated through the IN’s social networks (considering the sum of the number of interactions on Twitter, Bluesky, Instagram and Facebook).
Congratulations to the winners!
We look forward to seeing you in the next edition!
Organizing Comittee:
Verónica Murcia Belmonte
Augusto Escalante
La entrada Results Announcement V SciencePhoto_IN 2025 se publicó primero en Instituto de Neurociencias de Alicante.
New CosmoHub frontend released
This major update brings a modernized interface and significant improvements to data visualization
Closing event of the Quantum Communications Complementary Plan
The event was hosted in ICFO
Closing event of the IN-CAEM project
The event was hosted in ALBA Synchrotron
How Your Expectations Can Deceive You About Treatment Effectiveness
.png?itok=CiZa5-0e "Cómo tus expectativas pueden engañarte acerca de la efectividad de los tratamientos")
A new investigation, conducted by Aranzazu Vinas and Helena Matute of the University of Deusto, Bilbao, and Fernando Blanco of the CIMCYC at the University of Granada, highlights the dangers of incorrectly classifying patients. These dangers range from fostering the unfair distribution of healthcare resources to modifying the perceived efficacy of treatments.
Seguir leyendo
Cómo tus expectativas pueden engañarte acerca de la efectividad de los tratamientos
Una nueva investigación, realizada por Aranzazu Vinas y Helena Matute, de la Universidad de Deusto, Bilbao, y Fernando Blanco, del CIMCYC, Universidad de Granada, señala los peligros de clasificar a los y las pacientes de manera incorrecta, que va desde fomentar el reparto injusto de los recursos sanitarios hasta modificar la percepción de eficacia de los tratamientos.
Seguir leyendo
Defensa tesis doctoral: «Novel phosphonate-based metalorganic frameworks: from design to applications»
El próximo 2 de diciembre a las 11:00 horas tendrá lugar la defensa pública de la tesis doctoral de Rubén Serrano Nieto desarrollada en la Unidad de Materiales Porosos Avanzados […]
La entrada Defensa tesis doctoral: «Novel phosphonate-based metalorganic frameworks: from design to applications» se publicó primero en IMDEA ENERGÍA.
First comprehensive investigation shows large support for core ideas of degrowth, but not the label
The first major study into public attitudes toward degrowth – the notion that high-income economies should prioritise wellbeing over growing production – reveals significant public support for its key ideas across both the UK (74-84%) and US (67-73%).
Premio para el estudio que presenta una nueva inmunoterapia celular para la leucemia linfoblástica aguda de células B
Un estudio que presenta una nueva inmunoterapia celular para mejorar el tratamiento de la leucemia linfoblástica aguda de células B (B-ALL), del que son autores investigadores del Centro Nacional de Investigaciones Oncológicas (CNIO) y del Instituto de Investigación contra la Leucemia Josep Carreras, ha sido premiado en el reciente congreso de la Sociedad internacional para la Inmunoterapia del Cáncer.
Titulado CD22 CAR-T cells secreting CD19 T-cell engagers for improved control of B-cell acute lymphoblastic leukemia progressiony publicado en Journal for ImmunoTherapy of Cancer (JITC), el estudio “destaca el potencial de la terapia CAR-STAb-T en situaciones clínicas complejas, y subraya su ventaja frente a las terapias CAR-T convencionales, que no se han mostrado del todo efectivas a largo plazo”, explican sus autores principales Luis Álvarez-Vallina, jefe de la Unidad de Investigación Clínica en Inmunoterapia del Cáncer Hospital Universitario 12 de Octubre-CNIO, y Clara Bueno y Pablo Menéndez, del Instituto de Investigación contra la Leucemia Josep Carreras.
Javier Arroyo, investigador del grupo de Álvarez Vallina en el Hospital Universitario 12 de Octubre, y Aida Falgás, del Instituto de Investigación contra la Leucemia Josep Carreras, son primeros coautores del trabajo.
El premio 2025 JITC Best Immune Cell Therapies and Immune Cell Engineering Paper Award reconoce la novedad y el impacto del enfoque expuesto en el trabajo, junto con su validación en modelos tumorales de pacientes.
Biespecíficos y CAR-T, en uno
La leucemia linfoblástica aguda de células B (LLA-B) es un tipo de cáncer de la sangre muy agresivo. Es el más frecuente en la infancia -constituye el 35% de los tumores pediátricos-, pero afecta a personas de cualquier edad.
La primera opción de tratamiento para la LLA-B hoy día es la quimioterapia, basada en administrar tóxicos que eliminan células tumorales. Cuando no funciona se emplea la inmunoterapia, que pasa por activar contra el tumor a las propias defensas del organismo.
En concreto, se administran anticuerpos biespecíficos, que ponen en contacto a las células defensivas linfocitos T con las células tumorales. Otra opción es la inmunoterapia con células CAR-T, basada en extraer linfocitos T del paciente y modificarlos en el laboratorio para que, una vez reinyectados, puedan reconocer las células tumorales y atacarlas.
Ambas opciones, los anticuerpos biespecíficos y las CAR-T, han mejorado el tratamiento de los casos resistentes de leucemia linfoblástica aguda de células B. Pero algunos pacientes siguen sin responder, y más de la mitad de los que sí responden sufre recaídas.
El nuevo trabajo publicado ahora en Journal for Immunotherapy of Cancer presenta una tercera vía que combina las anteriores: una terapia CAR-T que produce un anticuerpo biespecífico.
“La relevancia clínica de este trabajo radica en su capacidad para reducir las recaídas de pacientes tratados con terapias CAR-T tradicionales”, explican los autores. “Además, no solo atacan directamente las células tumorales, sino que también reclutan linfocitos T no modificados, amplificando significativamente la respuesta inmunitaria”.
La entrada Premio para el estudio que presenta una nueva inmunoterapia celular para la leucemia linfoblástica aguda de células B se publicó primero en CNIO.
IMDEA Energía y la URJC exploran oportunidades de colaboración en materia de IA
Este lunes un grupo de expertos de la Escuela Técnica Superior de Ingeniería Informática de la Universidad Rey Juan Carlos ha visitado IMDEA Energía con el objetivo de explorar posibles […]
La entrada IMDEA Energía y la URJC exploran oportunidades de colaboración en materia de IA se publicó primero en IMDEA ENERGÍA.
Two ICIQ researchers appointed as new ICREA Research Professors
Prof. Katherine Villa and Prof. José A. Berrocal have been appointed as ICREA Research Professors, joining one of the most prestigious scientific communities in Catalonia. With their addition, ICIQ now hosts 11 ICREA researchers.
ICREA appointments recognise scientific excellence and grant researchers the freedom to pursue long-term, high-impact research without teaching or administrative obligations. The positions are permanent and equivalent to tenured posts, with ICREA scientists expected to contribute actively to strengthening and advancing the Catalan research landscape.
Prof. Villa highlighted its importance for her career and her group’s scientific direction. “This is a great honour and an important recognition of my scientific career and of the work carried out by our research group. This position will provide the stability and freedom needed to pursue our long-term scientific vision.”
Prof. Berrocal welcomed the appointment as both recognition and responsibility. “I accept this appointment with great honour. I see it as recognition of everything our group has achieved so far, and also as a responsibility for what the group will produce going forward. I hope that, as an ICREA researcher, I will be able to expand our network of collaborations and develop new joint projects.”
The importance of research in sustainability
Prof. Villa leads research on nanostructured photocatalytic systems based on multicomponent heterojunctions designed to convert pollutants into valuable chemicals and fuels. Her group also develops light-driven micro- and nanorobots that display autonomous motion, environmental sensing, and tuneable chemical activity, enabling applications in water purification, selective chemical transformations, and photodynamic therapy. Altogether, her research advances EU priorities in clean energy, water decontamination, and health.
Prof. Berrocal’s research focuses on stimuli-responsive polymers, materials that change their properties when exposed to external triggers such as heat, light, mechanical force or chemical reagents. By designing tailored macromolecular architectures and applying tools from organic and polymer chemistry, his group seeks to understand and control how these materials behave, contributing to the development of smarter and more efficient functional materials.
About ICREA
ICREA, the Catalan Institution for Research and Advanced Studies, is a foundation supported by the Catalan Government. Created to strengthen the competitiveness of the Catalan research system, it recruits exceptional scientists worldwide and integrates them into universities and research centres across Catalonia. Today, ICREA employs over 300 researchers in 48 host institutions, promoting excellence, international collaboration and equal opportunities.
La entrada Two ICIQ researchers appointed as new ICREA Research Professors se publicó primero en ICIQ.